Roche survey: Many millennial women skipping cervical cancer screenings
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect challenges in the United States.
Cancer
-
Riley Children’s Foundation lands $10M gift from Walther Cancer Foundation
Walther will provide a one-for-one match for donors who establish endowed children’s cancer research funds at Riley Children’s Foundation, a move that could result in at least $20 million for research of new treatments of children’s cancers.
Read More -
Radio icon Bob Kevoian discloses cancer diagnosis, launches podcast
Retired since 2015, Bob Kevoian made a rare appearance Wednesday on the syndicated “Bob & Tom” show to publicly reveal his diagnosis.
Read More -
SpectronRx teams with Belgian research center to make cancer therapies in Europe
The Indianapolis-based radiopharmaceutical company said it plans to help open a facility in Belgium to make therapeutic agents for cancer patients.
Read More -
Fishers biotech firm lands additional FDA approval for imaging product
Illuccix was first approved by the FDA in December 2021. The imaging agent is designed to target and “light up” cancerous cells, making it easier for oncologists to determine through a PET scan if the cells have spread to areas outside the prostate.
Read More
Articles
Drug manufacturing facility offers new hope in cancer fight
New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north-side warehouse transformed with $160 million into a clean-room manufacturing site for radiopharmaceutical cancer therapies.
Komen Tissue Bank hosting breast tissue donation drive ahead of WNBA All-Star festivities
The event, a partnership between the tissue bank and the city’s WNBA All-Star 2025 Host Committee, seeks 500 women to donate breast tissue for cancer research.
Power-lifting nurse helps Franciscan center focuses on prevention, wellness for cancer and cardiac disease
The Franciscan Healthy Living Center, which opened in 2020, is designed to help those who’ve been through cancer, heart disease, surgery or other serious conditions improve their health factors, including diet, fitness, sleep and mental health.
Weight-loss drugs may lower cancer risk in people with diabetes, study suggests
The findings were released Thursday by the American Society of Clinical Oncology and will be discussed at its annual meeting.
Roche Diagnostics hopes new self-collection HPV test will expand screening for cervical cancer risk
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
Community Health Network MD Anderson Cancer Center expands into Carmel
The Carmel center, which opened Monday, has 17 infusion rooms, eight rooms for clinical visits, a procedure room and a pharmacy.
Jury orders Monsanto parent to pay nearly $2.1B in Roundup weedkiller lawsuit
Bayer, which acquired Monsanto in 2018, has continued to dispute claims that Roundup causes cancer. But the company has been hit with more than 177,000 lawsuits involving the weedkiller and set aside $16 billion to settle cases.
Big Ten schools team up when it comes to cancer research
Indianapolis has been awash in Big Ten logos amid the conference’s basketball tournaments. But Indy is home to another sort of Big Ten gathering—one focused on improving cancer research.
Lilly acquires Scorpion Therapeutics in deal worth up to $2.5B
The Indianapolis-based drugmaker will acquire Scorpion’s STX-478, a once-daily oral treatment in early trials for breast cancer and other advanced solid tumors.
Community Health planning major expansion of north side cancer center
The Indianapolis-based hospital system wants to add 34,645 square feet to its MD Anderson Cancer Center at 7979 Shadeland Ave., on the Community Hospital North campus.
Blood test for colon cancer screening approved by regulators
The test isn’t a replacement for colonoscopies, but provides a noninvasive approach to screening.
Chemo drug cisplatin increases risk of long-term hearing loss, IU researchers find
The study followed a group of testicular cancer survivors for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations.
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs
At issue is whether a drug developed by Point Biopharma, based in Indianapolis, infringed on a patent issued in 2020 and assigned to Purdue Research Foundation.
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs
Novartis Manufacturing LLC told a committee of the City-County Council on Monday evening that it plans to spend up to $125 million to construct and equip a 79,000-square-foot-building for radiopharmaceutical manufacturing and distribution on the city’s west side.
Biotech firm nearing completion of Indy radioisotopes factory
Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.
New CEO takes reins at Little Red Door Cancer Agency
Mandy Pietrykowski succeeds Fred Duncan, who retired this week after leading the Indianapolis-based agency since 2009.
With stock trading near record high, Lilly embarks on ambitious 2023
The Indianapolis-based pharmaceutical company is preparing for one of its most ambitious years in memory for 2023, with plans to advance five new drugs into late-stage clinical studies and move four into regulatory review.
Screening procedure fails to prevent colon cancer deaths, large study finds
A 10-year study by researchers from Poland, Norway and Sweden published in the New England Journal of Medicine questions the benefits of colonoscopy screening exams.
Indianapolis biotech trying to fight cancer navigates bumpy road
Point Biopharma is moving aggressively to get its lead drug, a radioactive isotope called lutetium 177, through late-stage trials for prostate cancer.